Evaluation of Reader Training Processes

• Status: Completed
• Trial end date: 2014-08-01
• Target enrollment: 0
• Participant gender: All

Summary

This study is designed to evaluate the agreement between florbetapir F 18 scan interpretation in the clinic and by expert readers.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Avid Radiopharmaceuticals

Criteria

Inclusion Criteria:

• Scan obtained for clinical reasons

Exclusion Criteria:

• None